Travere Therapeutics Inc’s recently made public that its CHIEF FINANCIAL OFFICER Cline Christopher R. unloaded Company’s shares for reported $364.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Travere Therapeutics Inc’s recently made public that its CHIEF FINANCIAL OFFICER Cline Christopher R. unloaded Company’s shares for reported $364.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Travere Therapeutics Inc’s filing revealed that its CHIEF FINANCIAL OFFICER Cline Christopher R. unloaded Company’s shares for reported $364.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Travere Therapeutics Inc revealed its CHIEF EXECUTIVE OFFICER Dube Eric M unloaded Company’s shares for reported $0.17